AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia

PROCEPT AQUABEAM Study for the Treatment of Benign Prostatic Hyperplasia (ABS)

Single-arm prospective, interventional clinical trial. Results will be compared to a historical control in the treatment of benign prostatic hyperplasia

Inclusion Criteria:

• Male
• 50 - 80 years
• Moderate to severe BPH
• Subjects who have failed standard medical therapy

Exclusion Criteria:

• Size and width of prostate
• Medical condition or co-morbidities where BPH intervention would be contraindicated